How-To Geek on MSN

7 unusual programming languages that are worth taking a look at

By any measure, there is an enormous number of programming languages. Some lists contain hundreds, while the Historical ...

Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock

Recursion Pharmaceuticals (NASDAQ: RXRX) has been a pioneer in using artificial intelligence (AI) to improve the drug ...
Fierce Biotech

Chutes & Ladders—Recursion refreshes leadership with CEO swap

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
pharmaphorum

Recursion, Exscientia, and AI drug discovery’s moment of truth

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
pharmaphorum

AI biotechs Exscientia and Recursion agree $688m merger

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...